Andrew Ashe

Andrew Ashe

President bij VERVE THERAPEUTICS, INC.

Vermogen: 4 M $ op 31-03-2024

57 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Andrew D.
Ashe
is currently the President, COO & General Counsel at Verve Therapeutics, Inc. Prior to his current position, he held the role of General Counsel at Beacon Therapeutics (USA), Inc. from 2017 to 2018.
Before that, he served as Secretary, Executive VP & General Counsel at Dyax Corp.
from 2015 to 2016.
Additionally, Mr. Ashe was a Member-Business Law Practices at Nutter McClennen & Fish LLP and Prince Lobel Tye LLP.
He obtained his undergraduate degree from the University of Massachusetts and his graduate degree from George Washington University Law School.
He also holds an undergraduate degree from The Isenberg School of Management.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
14-02-2024 266 509 ( 0.34% ) 4 M $ 31-03-2024

Actieve functies van Andrew Ashe

Eerdere bekende functies van Andrew Ashe

BedrijvenFunctieEinde
APPLIED GENETIC TECHNOLOGIES CORPORATION General Counsel 01-08-2018
DYAX CORP. Chief Administrative Officer 01-01-2016
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Andrew Ashe in detail bekijken

Opleiding van Andrew Ashe

The Isenberg School of Management Undergraduate Degree
George Washington University Law School Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Andrew Ashe in detail bekijken

Connecties

59

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
VERVE THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit4

Health Technology

Commercial Services

Health Technology

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Andrew Ashe